DSM265: a novel drug for single-dose cure of Plasmodium falciparum malaria

Lancet Infect Dis. 2018 Aug;18(8):819-820. doi: 10.1016/S1473-3099(18)30374-8. Epub 2018 Jun 13.

Authors

Sabine Bélard¹, Michael Ramharter²

Affiliations

¹ Department of Pediatric Pneumology and Immunology, Charité University Medicine, Berlin, Germany; Berlin Institute of Health, Berlin, Germany.
² Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I Dep of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: ramharter@bnitm.de.

PMID: 29909070
DOI: 10.1016/S1473-3099(18)30374-8

No abstract available

Publication types

Comment

MeSH terms

Antimalarials*
Dihydroorotate Dehydrogenase
Humans
Malaria, Falciparum*
Malaria, Vivax*
Oxidoreductases Acting on CH-CH Group Donors
Plasmodium falciparum
Pyrimidines
Triazoles

Substances

Antimalarials
Dihydroorotate Dehydrogenase
Pyrimidines
Triazoles
DSM265
Oxidoreductases Acting on CH-CH Group Donors